98 related articles for article (PubMed ID: 12021895)
1. Gene therapy for pancreatic cancer based on genetic characterization of the disease.
Sunamura M; Yatsuoka T; Motoi F; Duda DG; Kimura M; Abe T; Yokoyama T; Inoue H; Oonuma M; Takeda K; Matsuno S
J Hepatobiliary Pancreat Surg; 2002; 9(1):32-8. PubMed ID: 12021895
[TBL] [Abstract][Full Text] [Related]
2. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for pancreatic cancer targeting the genomic alterations of tumor suppressor genes using replication-selective oncolytic adenovirus.
Sunamura M; Oonuma M; Motoi F; Abe H; Saitoh Y; Hoshida T; Ottomo S; Horii A; Matsuno S
Hum Cell; 2002 Sep; 15(3):138-50. PubMed ID: 12703544
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy for pancreatic cancer].
Sunamura M; Motoi F; Oonuma M; Hoshida T; Matsuno S
Gan To Kagaku Ryoho; 2002 Mar; 29(3):398-404. PubMed ID: 11915729
[TBL] [Abstract][Full Text] [Related]
5. [Development of gene therapy for pancreatic cancer].
Sunamura M; Motoi F; Onuma M; Abe H; Matsuno M
Nihon Rinsho; 2001 Jan; 59(1):98-103. PubMed ID: 11197871
[TBL] [Abstract][Full Text] [Related]
6. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
Mulvihill S; Warren R; Venook A; Adler A; Randlev B; Heise C; Kirn D
Gene Ther; 2001 Feb; 8(4):308-15. PubMed ID: 11313805
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic virotherapy as a novel strategy for pancreatic cancer.
Sunamura M; Hamada H; Motoi F; Oonuma M; Abe H; Saitoh Y; Hoshida T; Ottomo S; Omura N; Matsuno S
Pancreas; 2004 Apr; 28(3):326-9. PubMed ID: 15084981
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region.
Saito Y; Sunamura M; Motoi F; Abe H; Egawa S; Duda DG; Hoshida T; Fukuyama S; Hamada H; Matsuno S
Cancer Gene Ther; 2006 Mar; 13(3):242-52. PubMed ID: 16179928
[TBL] [Abstract][Full Text] [Related]
10. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
[TBL] [Abstract][Full Text] [Related]
12. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
[TBL] [Abstract][Full Text] [Related]
13. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK
Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616
[TBL] [Abstract][Full Text] [Related]
14. Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.
Salek C; Minarikova P; Benesova L; Nosek V; Strnad R; Zavoral M; Minarik M
Anticancer Res; 2009 May; 29(5):1803-10. PubMed ID: 19443408
[TBL] [Abstract][Full Text] [Related]
15. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
[TBL] [Abstract][Full Text] [Related]
16. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
Kim J; Cho JY; Kim JH; Jung KC; Yun CO
Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy.
Egami T; Ohuchida K; Yasui T; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
Cancer Sci; 2009 Oct; 100(10):1902-7. PubMed ID: 19604247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]